Repeated dosing improves oncolytic rhabdovirus therapy in mice via interactions with intravascular monocytes.

Autor: Naumenko V; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada. naumenko.vict@gmail.com.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada. naumenko.vict@gmail.com.; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada. naumenko.vict@gmail.com.; V. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, 119034, Russia. naumenko.vict@gmail.com., Rajwani J; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada., Turk M; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada.; Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada., Zhang C; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada., Tse M; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada.; Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada., Davis RP; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada.; Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada., Kim D; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada., Rakic A; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada., Dastidar H; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada., Van S; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada.; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada., Mah LK; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada.; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada.; Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada., Kaul EK; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada.; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada.; Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada., Chekhonin VP; V. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow, 119034, Russia.; Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow, 117997, Russia., Mahoney DJ; Alberta Children's Hospital Research Institute, Calgary, AB, T2N 4N1, Canada. djmahone@ucalgary.ca.; Arnie Charbonneau Cancer Institute, Calgary, AB, T2N 4N1, Canada. djmahone@ucalgary.ca.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada. djmahone@ucalgary.ca.; Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada. djmahone@ucalgary.ca., Jenne CN; Snyder Institute for Chronic Disease, Calgary, AB, T2N 4N1, Canada. cnjenne@ucalgary.ca.; Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada. cnjenne@ucalgary.ca.

Publikováno v: Communications biology [Commun Biol] 2022 Dec 19; Vol. 5 (1), pp. 1385. Date of Electronic Publication: 2022 Dec 19.